Tada
Recently you indicated in a post that you had done some financial models projecting apabetalone revenue. Do you have any revenue projections on DM's proposed rollout of a $5 per pill, two pill per day therapy for Covid-19 and variants - presumably 5-10 days per patient?
Only revenue will move this stock.
JMO